Control of Pain in Intravitreal Injections Using Topical NSAIDs
Status:
Completed
Trial end date:
2019-12-19
Target enrollment:
Participant gender:
Summary
Intravitreal injections (IVI) are a common form of treatment for multiple retinal
pathologies. The investigators hypothesize that an intervention with a topical NSAID will
alleviate pain experienced at intravitreal injection (IVI) and post-IVI. 46 participants will
be recruited, randomized into 1 of 3 treatment arms, and can expect to be on study for a day.